Skip to main content

Want a detailed portfolio tracker?

Mainz Biomed N.V. (MYNZ) Earnings (2025 - 2026)

Mainz Biomed N.V. (MYNZ) earnings from Mar 31, 2025 to Mar 31, 2026. The TTM Mainz Biomed N.V. (MYNZ) earnings is -$5.08M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Earnings

Quarterly Earnings

Mainz Biomed N.V. (MYNZ) Earnings CAGR table

PeriodCAGR
1 Year+1.60%

Annual Earnings change of Mainz Biomed N.V. (MYNZ)

YearEarningsChange
2026-$5.08M-68.66%
2025-$16M-24.95%
2024-$22M-17.87%
2023-$26M-0.34%
2022-$26M+125.75%
2021-$12M+1881.36%
2020-$590K-38.54%
2019-$960KN/A

Comparison Mainz Biomed N.V. (MYNZ) five years earnings CAGR with competitors

Mainz Biomed N.V. (MYNZ) five years earnings CAGR is 6.76%.

TickerNamefive years Earnings CAGRUpside
NOTVInotiv, Inc. Common Stock105.11%+1455.50%
PRPHProPhase Labs Inc91.63%+1256.00%
IQVIQVIA Holdings Inc27.63%+308.87%
MEDPMedpace Holdings Inc23.58%+248.96%
ISPCiSpecimen Inc17.65%+161.26%
PSNLPersonalis Inc16.49%+144.04%
BNRBurning Rock Biotech Ltd15.43%+128.34%
WATWaters Corp15.32%+126.69%
IMDXInsight Molecular Diagnostics Inc12.87%+90.43%
IDXXIdexx Laboratories Inc10.19%+50.81%
AAgilent Technologies Inc8.86%+31.10%
MTDMettler-Toledo International Inc8.29%+22.67%
ILMNIllumina Inc6.25%-7.53%
GHGuardant Health Inc6.12%-9.36%
MDXHMDxHealth SA4.58%-32.28%
XGNExagen Inc3.92%-42.04%
QGENQiagen NV3.42%-49.44%